Last updated on November 2019

Phase 3 Study of BGB-A317 Versus Sorafenib in Patients With Unresectable HCC


Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.